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ABSTRACT 
 
INTRODUCTION: Deceased donor organ shortage has made live donor (LD) programs 
essential. Many live donors are excluded. 
OBJECTIVES: 
1. To analyze a group of excluded donors to the paediatric LD program looking at 
exclusion rate, age, population group, relationship to recipient and reason for 
exclusion.  
2. To compare the group of excluded paediatric LD program donors to a group of 
excluded adult LD program donors. 
METHODS:  A retrospective case-file review.  
RESULTS:  In the paediatric group, mothers were referred more commonly. The main 
reasons for exclusion were hypertension, obesity, viral infections and immunological 
incompatibility. Donors to adult recipients were excluded more frequently and withdrew 
consent more often.  
CONCLUSION: Public health issues such as hypertension and obesity as well as the high 
incidence of HIV impact negatively on the LD kidney pool. Donors to paediatric recipients 
withdraw consent infrequently reassuring us that our selection of potential donors for 
evaluation is appropriate. 
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1.0 INTRODUCTION 
 
The number of adults and children reaching end stage renal disease (ESRD) and requiring 
renal transplantation is growing at an exponential rate (1) (2) and it is well known that 
kidney transplantation improves longevity and quality of life compared with dialysis 
therapy in subjects with ESRD. However, a serious problem is that the numbers of 
deceased donor (DD) allografts available for transplantation has changed little in the past 
20 years, which has made for longer times on DD waiting lists worldwide (1). In fact, in 
South Africa the number of DD allografts falls far below the requirements as compared 
with worldwide statistics (Prof AM Meyers, personal communication). 
 
 
 
1.1 The extent of the problem 
 
In South Africa at present, there are essentially only two paediatric renal units in the public 
service performing a significant number of transplants each year. They are Johannesburg 
Hospital and Red Cross Children’s Hospital in Cape Town. As a result, Johannesburg 
Hospital provides a service to a very large area, with patients being managed in our unit 
from as far away as Kwa-Zulu Natal, Limpopo, Free State and Mpumalanga as well as all 
children in ESRD from Gauteng.  
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The incidence and prevalence of ESRD in children in South Africa is not known. 
According to the 2001 Census, the population of Gauteng was approximately 8.8 million 
with approximately 2.8 million of the population children under the age of 19 years. The 
total population of all the provinces we serve is probably closer to 29.4 million with around 
12.6 million children under the age of 19 years (3). 
 
 
 
A national survey performed in Sweden reported a median annual incidence and 
prevalence of childhood severe chronic kidney disease (CKD) (Creatinine clearance (CCr) 
< 30 ml/min per 1.73 m2) of 7.7 and 21 per million of the age-related population (MARP) 
respectively (4). Due to a lack of national registries, incidence and prevalence data from 
developing countries primarily originates as reports from major tertiary care referral 
centers, and the nature of the data depends on local referral practices and accessibility to 
hospital care (5). A 15-year review of admissions from a university teaching hospital in 
Nigeria estimated the median annual incidence of severe CKD to be 3.0 per MARP, with a 
prevalence of 15 patients per million children (6).  
 
 
 
Based on the above figures we should be seeing anywhere between 36 to 90 new cases per 
year, but currently we only see around 10 to 12 new patients with ESRD per year and 
presumably many children with ESRD are not making it to our referral centre. Those that 
do get to Johannesburg for assessment face a shortage of dialysis facilities, and once on the 
transplant program, a long wait for a kidney, unless they are fortunate enough to have a 
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suitable and willing potential live donor. We have approximately forty children with ESRD 
awaiting renal transplantation at Johannesburg Hospital at any one time, some of whom 
have been waiting more than 3 years for a transplant.  Many more adult patients languish 
on the transplant list waiting for their chance to receive a donor kidney. 
 
 
 
1.2 Allograft source 
 
In South Africa, the refusal rates of family consent to allow recovery of potential DD 
allografts in the vast majority of the population have made the shortage of DD organs 
untenable. For example, it has been previously observed that the concept of living kidney 
donation has been accepted by black South Africans, with 80% of living donors 
approached saying they would be prepared to donate a kidney. This is however not the case 
for DD donation, with only 37.5% of potential donors approached saying they would be 
prepared to donate a kidney after death (7). Our experience is that, over the years, only a 
handful of black families gave consent to kidney retrieval from a DD when faced with the 
challenge (Prof AM Meyers, personal communication). Factors cited which may affect 
organ donation in black South Africans include ignorance, misconception and cultural 
beliefs (7). The growing need for kidney transplantation, and the better outcomes provided 
by living donation, are focusing transplant centre efforts on increasing living donation (8). 
In South Africa, proactive live donor (LD) programs have become essential to allow 
patients with ESRD to have a chance at a transplant.  
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Donor allograft source is remarkably different in paediatric transplantation compared with 
adult transplantation. In paediatrics, the use of LD allografts has increased steadily from 
42% in 1987 to 60% in recent reports from units in the developed world (9). Most of the 
allografts (83%) come from a parent (1). In adult transplantation LD allograft source is 
also increasing, though remains significantly lower than paediatric use (10).  
 
 
 
The paediatric renal unit at this hospital also follows this trend, with increasing numbers of 
LD kidneys being used over the past 10 years as fewer DD kidneys are made available to it. 
In the period 1995-1999, 24% (19/79) of all paediatric transplants at this hospital were LD 
transplants as compared to the period 2000-2004 where 54% (32/59) were from living 
donors (11). What is important to note is that, although in 1995-1999 only 7% (3/41) of 
transplants in black children were from LD grafts compared to 42% (16/38) for white, 
Asian and mixed race recipients, in the period 2000-2004 this improved to 52% (17/33) for 
the black recipients compared to 58% (15/26) for white, Asian and mixed race recipients 
(11). It is therefore reasonable to say that, with proper counselling and encouragement, in 
our unit all population groups have accepted the idea of LD transplantation as an ideal. 
 
 
 
LD transplants are associated with better outcomes in comparison with DD transplants due 
to a number of reasons, an important one being reduction of the time spent waiting for a 
transplant on dialysis (12). This trend has been noted in our unit too with actuarial 1-, 5- 
and 10-year graft survival being 88, 62 and 40% for LD grafts, and 80, 41 and 20% for DD 
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grafts (13). Using live donors also provides an important source of organs in an 
environment where demand for organs far exceeds supply.  
 
 
 
A major problem is that many live donors who are referred for evaluation of feasibility to 
donate a kidney are turned down for various reasons and the recipients end up having to 
wait for a DD graft (14)(15). This problem is markedly compounded in our DD pool where 
up to 60-70% of potential donors are found to be unsuitable (Prof AM Meyers, personal 
communication). 
 
 
 
1.3 Benefit and risk to the donor 
 
The benefit to the donor is mainly psychological with a sense of increased self esteem, and 
the potential donor needs to carefully weigh up the decision to donate a kidney (16) (17) 
(18). Of course, the work up is extensive and the potential donor is appraised with a very 
critical eye. This implies that very often asymptomatic but potentially serious pathology is 
detected during the work up. Although this would exclude the donor from donating, it does 
do the donor a service in that they can then be referred on for appropriate management.  
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In the absence of medical contraindications, most centres consider the risk to the donor to 
be low and far outweighed by the benefits to both the recipient and the donor (16) (17) (18). 
Death as a result of donor nephrectomy is very uncommon (17), as are long term 
postoperative complications.  
 
 
 
Donating a kidney for transplantation could potentially cause hypertension and renal 
insufficiency (19). Experimental data has demonstrated that although compensatory 
hypertrophy in the remaining kidney does take place minimizing the reduction in GFR (20) 
(21), maladaptive consequences for glomerular function, with sustained hyperfiltration and 
striking changes in renal morphology, occur in rats after reduction of renal mass (22). 
However, studies examining the question of long term renal function in human kidney 
donors have found that although creatinine clearances are reduced after nephrectomy (23) 
(24) (25), the overall consensus is that in long term follow-up of living donors, no evidence 
of progressive renal deterioration has been found (26). Results of a meta-analysis suggest 
that organ donation does not cause a progressive decline in renal function or increase in 
proteinuria, despite the reduction in renal mass being associated with an increased serum 
creatinine (19).  
 
 
 
A number of studies have reported on the natural history of hypertension in patients who 
underwent unilateral nephrectomy. The results vary with some papers reporting little or no 
increased risk for developing hypertension when compared with the general population or 
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matched controls (24) (26) (27), and others reporting an increase in the incidence of 
subsequent hypertension especially in patients with risk factors (such as a strong family 
history of hypertension) before donation or who had borderline hypertension (28) (29) (30). 
In the meta-analysis mentioned above, it was shown that although there was a small 
increase in blood pressure after donation, it did not appear to be of sufficient magnitude to 
result in a diagnosis of hypertension. It was unclear whether this increment in blood 
pressure should discourage donation in patients with borderline hypertension (19).  
 
 
 
In summary, the risk of later complications such as hypertension and significant decreased 
renal function appears to be small (19) (23) (24) (25) (26) (27) (31). Careful donor 
selection will reduce this risk still further, but the small possibility of potential 
complications post donation necessitates life-long close follow-up of donors. Unfortunately, 
due to various factors and in spite of vigorous education and counselling, our donor 
follow-up is less than ideal. We achieve excellent donor follow-up rates in only 30% of our 
donors and adequate follow-up rates in a further 10% of donors. This leaves around 60% of 
our donors lost to follow-up. Also of concern is that it has been noted that a significant 
proportion of our donors who do come for follow-up are being found to have developed 
hypertension (Prof AM Meyers, personal communication).  
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1.4 Donor evaluation 
 
In our hospital the evaluation of the potential donor is carried out by a separate donor 
evaluation clinic managed by an adult nephrologist with no connection to the recipient. 
This puts the donor’s well being first, preventing any conflict of interest which may arise 
should the donor be worked up by the recipient’s doctors, and is in keeping with guidelines 
from other respected centres (32). The aim of the donor evaluation process is to exclude 
individuals who may be put at risk by donating a kidney. It should also ensure that the 
recipient is not compromised by being given a suboptimal graft, by acquiring an infection 
such as Human Immunodeficiency Virus (HIV) or viral hepatitis from the donor, or by 
having a malignancy transferred from donor to recipient, all of which have been previously 
described (33) (34) (35) (36) (37). 
 
 
 
Donor evaluation guidelines have been developed to ensure that the benefits to the 
recipient far out way the risk to both donor and recipient (16). Donors are carefully 
informed of the inconveniences and short term risks of diagnostic procedures, the pain and 
discomfort of nephrectomy, and the potential socio-economic and psychological risks 
associated with kidney donation (16).  
 
 
 
 Potential donors under the age of 18 years are not considered as it is felt that they cannot 
give informed consent. This is in keeping with international norms and practice (15). 
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Due to the shortage of DD kidneys, one possible way to increase the number of available 
kidneys has been reduction of the minimum criteria for acceptance of a prospective organ 
by including donors over the age of 60 years (38). It is difficult to define an upper age limit 
for donors, with one survey showing 27% of centres having no age cut-off while 60% of 
centres have some cut-off between the ages of 55 and 75 years (15).  
 
 
 
The problem with using older donors is that there is a well described rate of decline in 
creatinine clearance with advancing age (39), and although compensatory renal 
hypertrophy has been found to take place in donors up to the age of 74, the greatest 
changes in renal size are observed in donors under the age of 40 (21). These two factors, 
among others, may place the older donor at risk.  
 
 
 
Short and long term graft survival rates have been reported to be similar for kidneys from 
younger compared with older living donors (40)(41)(42)(43), but other studies still report 
poorer long term graft survival in kidneys from donors over the age of 60 years (38). 
Reluctance to use kidneys of older donors has been based on histological changes found in 
the kidneys of elderly donors such as small vessel wall thickening, progressive glomerular 
sclerosis and tubular atrophy (44). When these grafts suffer hemodynamic changes, acute 
tubular necrosis, graft rejection, sepsis or injury from nephrotoxic drugs, the recovery 
might be incomplete and there may be a higher risk of poor graft function and shortened 
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graft survival rate (43).  For the above reasons our policy is not to use potential live donors 
who are above the age of 55 years. 
 
 
 
Once the donor has been counselled and reassured that they can withdraw from the work-
up at any time, ABO testing is done to ensure that there is no ABO incompatibility 
between donor and recipient. Although a few transplants have been successfully performed 
across the ABO barrier using a more aggressive immunosuppressive protocol 
preoperatively and postoperatively (45), current recommendations are that ABO – 
incompatible transplants should generally not be performed (16). At present our unit would 
not refer a donor for evaluation should there be ABO incompatibility, in keeping with this 
guideline. 
 
 
 
Contraindications to donation discovered during the course of a preliminary medical 
evaluation may save time, money and potentially adverse (physical and psychological) 
effects of a more extensive evaluation (16). The medical evaluation includes a history and 
physical examination with careful attention being paid to a history of hypertension, 
nephrolithiasis, proteinuria, haematuria, oedema or renal parenchymal infection (16).  
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A history of established hypertension or renal disease may preclude the use of the donor 
and obviate further evaluation, and similarly, a history of multiple cardiovascular risk 
factors, diabetes mellitus, malignancy or systemic disease with potential renal involvement 
may make further evaluation unnecessary (16). A family history of hypertension, renal 
disease and diabetes is also sought, and if significant, would require careful assessment 
before accepting that donor. Physical examination is aimed at detecting obesity and other 
surgical or anaesthetic risks, as well as finding evidence of hypertension, chronic infections, 
malignancy, chronic pulmonary and cardiovascular disease and chronic renal disease (16).  
 
 
 
Once the donor is been judged to be a good candidate, further testing is carried out to 
assess the donor’s cardiopulmonary capacity, renal function and immunological 
compatibility with the recipient, and an angiogram is performed to assess the renal 
vasculature. 
 
 
 
1.5 Potential reasons for exclusion of a live donor 
 
Hypertension is defined as a systolic blood pressure of 140 mm Hg or greater and/or a 
diastolic blood pressure of 90 mm Hg or greater in subjects who are not taking 
antihypertensive medication (46), and is reported as being one of the most common 
reasons for excluding a candidate before angiography (14). In a study entitled “Selection 
criteria for the evaluation of living related donors”, Riehle et al reported that of 159 
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candidates, 91 were accepted and underwent nephrectomy, 33 were accepted but did not 
undergo nephrectomy and 35 were rejected. Of the 68 potential donors who were not used, 
26.5% (18/68) were not used because of hypertension (14). Bia et al reported that up to 
64% of centres will exclude a donor taking an antihypertensive agent and 54% exclude 
those with persistent borderline hypertension (15). The balance of data seems to indicate 
that donating a kidney can worsen existing hypertension and that it is therefore best to 
exclude potential donors who have hypertension (16). The possibility of an increased risk 
for hypertension in at least some living donors requires that the long term follow-up of 
donors include blood pressure monitoring and treatment (16). 
 
 
 
In the donor evaluation the role of 24 hour blood pressure monitoring versus multiple 
office measurements is unclear (16), and our donors are evaluated using both office 
measurements and ambulatory blood pressure measurement where indicated.  
 
 
 
Obesity is steadily becoming the greatest health problem in the developed world and is 
defined as a body mass index (BMI) greater than 30 (47) (48). Obesity has numerous 
serious medical sequelae such as type 2 diabetes, the metabolic syndrome (insulin 
resistance and hyperinsulinaemia, dsylipidaemia, essential hypertension, type 2 diabetes 
and an increased risk of cardiovascular events), obstructive sleep apnoea and increased 
death rates from cancer (48) (49). Obese donors may provide the anaesthesiologist with a 
considerable challenge due to the effect of obesity on the upper airway, lung volumes, 
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cardiovascular system and drug handling (50). In addition, of importance to potential 
kidney donors is that obesity has been found to be a significant risk factor for the 
appearance of proteinuria and progressive renal failure after unilateral nephrectomy (51). 
Due to the above risk factors, 16% of transplant centres will exclude donors with moderate 
obesity (15) although in the study by Riehle et al, of the 68 potential donors who were not 
used,  only 1/68 (1.5%) was not used because of obesity (14). 
 
 
 
Smoking has been shown to predict the development of proteinuria in study subjects 
independent of hypertension and diabetes mellitus (52), and the association of smoking and 
kidney damage in the healthy population has also been documented (53). In the survey by 
Bia et al referred to above, 16% of transplant centres rejected donors with heavy cigarette 
smoking (15). Our centre does not specifically exclude donors who smoke but insists on 
smoking cessation if possible and lung function tests for all candidates. Poor lung function 
would exclude a donor from donating. 
 
 
 
HIV has been transmitted from both infected deceased donors as well as from infected 
living related donors with the development of acquired immunodeficiency syndrome and 
ultimately death in the recipient (33) (34).  For this reason, organ donor guidelines 
necessitate HIV infection in the donor to be a contraindication to organ donation (16) (54). 
 
 
14 
 
In addition to their effects on the liver such as hepatocellular carcinoma and cirrhosis, both 
hepatitis B and hepatitis C have been implicated in the pathogenesis of chronic 
glomerulonephritis (55) (56) (57). Given this risk to the donor, living kidney donation by 
an individual with chronic viral hepatitis is not justified (8). Also, not only is there a risk to 
the donor, but there is also a risk to the recipient. Transmission of hepatitis B and C from 
infected donors to recipients, with resultant development of post transplant liver disease, 
has been documented (35) (36) (58). In the study by Riehle et al, of the 68 potential donors 
who were not used, 3% (2/68) were not used due to chronic hepatitis (14). In our centre the 
policy was not to use a donor who is hepatitis B or hepatitis C positive. Recently however, 
as in some other units (58), we have begun to permit the use of kidneys from HBcAb (+), 
HBIgM (-), HBsAg (-) donors for immunized recipients.   
 
 
 
Renal dysfunction in the donor is also an important reason for donor exclusion. Almost all 
centres (98%) working up potential kidney donors will perform a urinalysis, urine culture 
and renal angiogram on potential donors (15). A number of tests are used to assess 
glomerular filtration rate (GFR) such as serum creatinine, blood urea nitrogen and 
calculated creatinine clearance, but only 10% of centres use radio nucleotide scanning 
routinely (15). 58.8% of centres will exclude an otherwise healthy donor if the creatinine 
clearance is under 80 ml/min per 1.73 m2, but other centres have a lower threshold for 
exclusion with 21% of centres accepting a GFR of more than 60 ml/min per 1.73 m2 and 
2.4% of centres accepting a GFR of more than 40 ml/min per 1.73 m2 (15). Although some 
studies suggest that perhaps our current standards are too high (59), it is generally accepted 
that the donor’s renal function should be normal after correction for age and gender (16). 
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In the study by Riehle et al, although some potential donors were turned down due to a 
variety of renal anatomy abnormalities detected on screening, none were turned down due 
to a low creatinine clearance (14). 
 
 
 
Inadequate urine collection, diet and other factors may result in a low creatinine clearance 
rate in people with normal renal function, and so an alternative method for measuring GFR 
should be considered before excluding a potential donor because of a low GFR (8) (16).  
Our unit uses the Constable 51Cr-EDTA isotopic plasma clearance technique which, like 
the other isotopic plasma clearance procedures, gives the best approximation to true GFR 
(8). We would exclude a potential donor if they have a GFR of less than 85 ml/min per 
1.73 m2 using the 51CrDTPA scan.  
 
 
 
The most frequently encountered anatomic variation in the kidney is that of multiple renal 
arteries, with 25% being unilateral and 6.5% bilateral in potential living kidney donors (60). 
The use of kidneys with multiple renal arteries from living related donors has been 
associated with increased risk to the allograft. Complications such as ureteric fistulae due 
to interference with the blood supply to the ureter during dissection of the inferior polar 
artery, and acute tubular necrosis and graft loss due to thrombosis or ligation of a polar 
artery have been reported (61). 
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However, Benedetti et al, analysing a combination of DD and LD transplants, found that 
kidney grafts with multiple arteries can be implanted with short and long term results equal 
to those with single arteries (62). They found no difference between short and long term 
graft outcomes based on the number of renal arteries and the technique used for 
reconstruction and anastomosis. Graft survival was excellent with multiple anastomoses 
and with multiple arteries converted to a single artery by bench reconstruction. Urologic 
complications did not increase, and no difference was found in the vascular complication 
rate between deceased donor and living related donor grafts (62).  
 
 
 
Deceased donor kidney procurement using the en bloc technique has helped to decrease 
significantly accidental injury to polar arteries during donor nephrectomy (62), and kidneys 
from living donors with multiple renal arteries have been successfully engrafted by 
applying appropriate renovascular surgical techniques (60) (63). In the study by Riehle et 
al, there were no donors excluded due to multiple renal arteries (14). Our unit would 
discuss potential donors who have multiple renal arteries with both teams of surgeons and 
then decide on an individual basis which donors to accept. 
 
 
 
Nephrolithiasis is at least a relative contraindication to living donor nephrectomy because 
of the future risk that recurrent stones, obstructions, and infections will injure the 
remaining kidney (16). Nephrolithiasis not only places the donor at risk, but cases of 
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inadvertent transplantation of a kidney with stones have been described with resultant 
hydronephrosis requiring surgical intervention (64) (65). 
 
 
 
Lee et al followed up 50 patients with urolithiasis after unilateral nephrectomy, all of 
whom had a normal remaining kidney at the time of nephrectomy. Thirty percent had 
recurrent stones, two developed acute reversible anuria, and one had proteinuria and 
progressive renal failure 47 months after nephrectomy. Patients with metabolic stone 
disease had a greater recurrence rate (66).  
 
 
 
Due to the continued formation of stones in a significant number of patients undergoing 
nephrectomy, and the associated risk of anuria, nephrectomy in patients with 
nephrolithiasis for the purpose of donation needs to be undertaken very carefully (8). A 
history of nephrolithiasis automatically eliminates a donor in 34% of centres, while 8% 
accept such donors if no stones are present and 48% accept them if no stones are present 
and metabolic studies are normal (15). In some guidelines, a history of stone formation is 
not considered to be an absolute contraindication if the donor has passed only one stone or 
has stone disease that has been inactive for 10 years, and if the nephrolithiasis is not 
currently present on radiographic studies (16).  
 
 
18 
 
To be certain that there is no risk for active stone disease in the future, it is recommended 
that the potential donor with inactive stone disease should be carefully screened for risk 
factors and metabolic abnormalities, and should such a donor be accepted, life long 
medical follow up should include periodic risk assessment and medical treatment to 
minimize risks that are subsequently discovered. A general recommendation to avoid 
dehydration should also be given (16). In the study by Riehle et al, of the 68 potential 
donors who were not used, only 1/68 (1.5%) was not used because of renal calculi (14). In 
our unit, previous nephrolithiasis is a total contraindication to donation. 
 
 
 
Women should not be evaluated while they are pregnant (16). Cytomegalovirus (CMV) is 
also screened for because transplantation of a kidney from a donor who is CMV positive to 
a recipient who is CMV negative is associated with a higher risk for CMV disease in the 
recipient (16) (67). Although CMV positivity will not preclude the use of that donor, 
prophylactic measures in the recipient may be warranted (16) (67). Screening for 
tuberculosis (TB) with a chest X-Ray (CXR) is also performed as there is some risk that 
TB may be transmitted by the transplanted kidney (68) (69). Active TB is a 
contraindication to donation (16).  
 
 
 
Even if the potential donor has no medical reasons for exclusion as a potential donor, there 
are other reasons that a donor may not be used. For example, there may be a positive cross 
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match between donor and recipient. In the study by Riehle et al, of the 68 potential donors 
who were not used, 10.3% (7/68) were not used because of a positive cross match (14). 
 
 
 
The recipient may receive a DD organ while the LD work up is in progress. This could 
happen if the recipient was placed on the DD list by mistake, or if the recipient was 
deliberately put on the DD list because the potential LD work up was delayed for some 
reason such as financial issues or donor weight loss problems. True mistakes are 
regrettable because they take a DD kidney, which could have been used by someone else, 
out of the donor pool. In the study by Riehle et al, of the 68 potential donors who were not 
used, 5.9% (4/68) were not used because the recipient received a DD organ (14).  
 
 
 
Death of the recipient may occur while waiting for the donor to complete their work up. In 
the study by Riehle et al, of the 68 potential donors who were not used, 10.3% (7/68) were 
not used due to recipient disease or death (14). Quicker referral of potential donors, quicker 
work-ups, and better medical care of the recipient could all prevent this outcome. 
 
 
 
Transfer of the recipient and donor to another hospital for the transplant may occur. 
In the study by Riehle et al, of the 68 potential donors who were not used, this occurred in 
5.9% (4/68) (14). Although the recipient received a graft in the end, perhaps in this era of 
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cost consciousness, the transplanting hospital should consider reimbursement of some of 
the costs incurred during the work-up. 
 
 
 
Withdrawal of consent is a particularly vexing problem as it results in a waste of time, 
effort and cost on the part of the evaluation unit, not to mention disappointment to the 
recipient.  More careful selection and counselling of potential donors may reduce the 
incidence of withdrawal of consent. In the study by Riehle et al, of the 68 potential donors 
who were not used, 14.7% (10/68) were reported as refusing to donate after passing the 
initial screening process (14). This came to 6.2% (10/159) of all the referred donors in that 
study. 
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2.0 THE AIMS OF THE STUDY 
 
2.1 To analyze a group of excluded paediatric LD program donors at Johannesburg 
Hospital 
 
We set out to determine the rate of exclusion of potential donors to our paediatric LD 
transplant program and then to analyze a group of excluded potential live donors. We 
aimed to document their age, their relationship to the recipient, and the reason for their 
exclusion as donors. We also set out to document and analyze any differences between the 
different population groups. This was done with a view to streamlining the referral of 
potential donors. We hoped to generate data which would give us direction on whether or 
not, in the light of the severe shortage of donor organs, some of our exclusion criteria are 
too strict and perhaps could be relaxed. 
 
 
 
2.2 To compare the group of excluded paediatric LD program donors with a group of 
excluded adult LD program donors  
 
We aimed to compare our data on excluded paediatric LD program donors to research done 
previously by Meyers et al on excluded donors to the adult LD program at our hospital 
(70). We aimed to see if there were any differences in their ages, rates of exclusion and 
reasons for exclusion. We theorised that there would be considerably fewer reasons to 
exclude potential paediatric LD program donors in comparison to the adult group. This 
notion was backed by the following postulates: 
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1. The donors would be younger and therefore generally fitter than their adult counterparts. 
2. There would be less obesity in a younger age group of donors. 
3. Most importantly there would be less hypertension, especially borderline hypertension. 
This is because in the black adult recipients, the prevalence of ESRF due to essential 
familial hypertension is about 60%. The potential donors to these adult recipients may have 
inherited the same genetic predisposition for hypertension. 
4. We also postulated that, in the paediatric donor population, the prevalence of hepatitis B 
and C and HIV may be lower. 
5. Finally, we thought that the withdrawal of permission, which was frequently found in 
the adult donors, would be lower in the paediatric donors. 
 
 
 
If the above postulates were proven as true, we would be much more comfortable pushing 
for a proactive paediatric LD program than perhaps an adult program. This is particularly 
so remembering the phrase in the Hippocratic Oath “Non Nocere”. There are many pre-
eminent nephrologists in the world who still feel that LD transplantation is, nearly always, 
difficult to justify (Prof B Brenner, personal communication with Prof AM Meyers). 
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3.0 MATERIALS AND METHODS 
 
3.1 Donor evaluation at the Johannesburg Hospital 
 
The recipients are managed by the paediatric renal unit at the Johannesburg Hospital. After 
a careful interview with the attending paediatrician, the paediatric unit senior professional 
nurse and the paediatric unit social-worker, a volunteer from the family is accepted for 
evaluation. ABO testing is performed by the paediatric unit on the potential donor, and the 
donor is then referred on to the donor evaluation clinic if they are compatible with the 
recipient. The donor must be between the ages of 18 and 55 years. 
 
 
 
The history, physical examination and further explanation of the procedures, risks and 
potential outcomes of the work-up and donation are performed by a nephrologist who 
manages the transplant donor clinic. Ambulatory blood pressure monitoring is performed 
where indicated and an assessment for the metabolic syndrome is performed on obese 
patients. Standard blood tests are performed, namely a full blood count with differential 
and platelets, a urea, creatinine and electrolytes, liver function tests, fasting lipogram and 
blood sugar, thyroid function tests and HIV, CMV and Hepatitis B and C serology. Iron 
studies are done on all women and iron replacement therapy given when required. A 24 
hour urine collection is collected for creatinine clearance calculation and protein and 
micro-albumin excretion measurement. Urine is also sent for microscopy, culture and 
sensitivity testing. 
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A chest X-Ray, renal ultrasound, pulmonary function test when required and cardiology 
assessment are done by the respective specialist clinics and if all of the above are normal, a 
Constable 51CrDTPA scan is performed to assess GFR. Formal human leukocyte antigen 
(HLA) testing of the donor and recipient is performed, and a donor specific blood 
transfusion (DST) is given to each recipient after which a 51Cr release assay test is done to 
detect potential recipient sensitisation. Recently DST has been abandoned except in 
specific cases. CT Subtraction Angiography is then done to look for multiple renal vessels, 
with delayed films to assess drainage of the renal systems. The surgeons on both the donor 
and recipient teams review the vessel anatomy. 
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3.2 Reasons for exclusion of a potential donor 
 
1. A history of donor hypertension, renal insufficiency or renal surgery, 
nephrolithiasis, cancer, co-existing diabetes, significant heart disease, chronic lung 
disease or drug abuse would be regarded as contraindications for donating. 
2. A family history of renal disease and diabetes may, after extensive testing, preclude 
the use of that donor.  
3. The presence of hypertension. Hypertension is defined as a systolic blood pressure 
of 140 mm Hg or greater and/or a diastolic blood pressure of 90 mm Hg or greater 
in subjects who are not taking antihypertensive medication (46), and is screened for 
by manual office measured blood pressure using a correct sized cuff and a 
sphygmomanometer on three separate occasions. More recently ambulatory blood 
pressure monitoring has been done using a Dynamap device when required. 
4. The presence of obesity. Obesity is defined as a BMI greater than 30 (47) assessed 
using a calibrated scale and stadiometer. 
5. The presence of HIV, Hepatitis B and/or Hepatitis C. 
6. The presence of diabetes mellitus, ischemic heart disease, pulmonary dysfunction, 
malignancy or any other chronic disease. 
7. The history or presence of renal calculi. 
8. The presence of immunological cross reactivity between donor and recipient using 
a 51Cr release assay. 
9. A GFR of less than 85 ml/min per 1.73 m2 using a Constable 51CrDTPA scan.  
10. The presence of more than two renal arteries bilaterally. 
11. The presence of psychological problems. 
12. Donor ages less than 18 years or above 55 years.  
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3.3 Study method 
 
A retrospective case file review was conducted looking at all data of potential donors 
excluded from our paediatric LD program from January 1989 to December 2004.  
 
 
 
Data was collected from the files on the following parameters: 
1. Donor hospital number 
2. Donor age 
3. Donor sex 
4. Donor race 
5. Donor relationship to the recipient viz. father, mother, other (sibling, other relative, 
non related live donor) 
6. The main exclusion criterion e.g. obesity, hypertension, concomitant renal 
dysfunction, congenital anatomical abnormalities of the renal system or renal 
vessels, systemic disease, psychosocial issues such as withdrawal of consent by the 
donor, HIV, other viruses 
 
 
 
Data was entered directly into a Microsoft Excel spreadsheet for storage and analysis. See 
the attached data capture sheet (APPENDIX A). 
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All files of excluded potential donors are held by the unit which assesses these patients and 
were easily accessible. These files are kept in a locked room in the adult renal department 
with access restricted to the senior professional nurse in charge and the head of the 
assessment clinic. 
 
 
 
We also compared our data to similar research done previously on excluded adult LD 
program donors (70). 
 
 
 
3.4 Ethics 
 
Access to files and data collection was limited to the investigator and strict levels of 
confidentiality were adhered to at all times. At no point was it necessary to identify a 
subject in any way in the final paper, and in the data collection, a unique study number was 
assigned to each participant in order to maintain patient confidentiality.  
 
 
Ethics approval was obtained from the ethics committee of the University of the 
Witwatersrand (Reference number: M050940). 
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 3.5 Statistical analysis  
 
Statistical analysis was done using the statistical package Stata Release 8.0 statistical 
software and advice was obtained from a statistician. 
 
The Student’s t test was used to compare the ages of the different groups. 
 
Comparisons of rates of exclusion, rates of referral of different relatives and reasons for 
exclusion for the different groups were performed using the chi-square test where 
appropriate.  
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4.0 RESULTS 
 
4.1 The excluded paediatric LD program donors  
 
4.1.1 Division of the cohort of excluded potential donors into two groups for analysis 
 
Between January 1989 and December 2004 111 potential living donors to the paediatric 
LD program were evaluated. 51 were excluded and 60 were accepted. All 60 accepted 
donors donated their kidney to their recipient. All files of the 51 excluded donors were 
complete and available for analysis 
 
 
 
The group of 51 excluded donors was made up of 22 black African subjects who, for the 
purposes of the study, were labelled the black donor group and 29 other race subjects who, 
for the purposes of the study, were labelled the other donor group. The group of 29 other 
race subjects was made up of 24 Caucasian, 3 Asian and 2 mixed race excluded donors.  
 
 
 
Because the Asian and mixed race groups were felt to be similar to the Caucasian group in 
terms of their socio-economic standing and cultural beliefs, and because of the small 
numbers of Asian and mixed race excluded potential donors, these two groups were added 
to the group of Caucasian donors to create the group labelled other donors.  
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4.1.2 The rate of exclusion of the paediatric LD program donors 
 
During the study period 111 potential living donors (PLD) to the paediatric LD program 
were evaluated. 51 were excluded from donating and 60 were accepted for donation giving 
an overall exclusion rate of 45.9% (51/111).  
 
 
 
The group of 111 potential donors to paediatric recipients was made up of 41 black donors 
of which 22 were excluded and 70 other donors of which 29 were excluded, giving 
exclusion rates of 53.7% (22/41) and 41.4% (29/70) respectively for the two groups (see 
Table 4.1). There was no statistical difference found in the rate of exclusion between the 
black donor group and the other donor group using the chi-square test (p=0.21).  
 
 
 
Table 4.1 Rate of exclusion of paediatric LD program donors 
 Black donors Other donors Total 
PLD 41 70 111 
ALD 19 41 60 
XLD 22 29 51 
% excluded 53.7% 41.4% 45.9% 
PLD = potential living donor                                           
ALD = accepted living donor 
XLD = excluded living donor 
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4.1.3 The age of the excluded paediatric LD program donors 
 
The average age of the excluded potential donors to the paediatric LD program was 37.1 
years (SD +/- 8.08) with the average age for the group of black donors being 36 years (SD 
+/- 7.4), and the average age of the group of other donors being 38 years (SD +/- 8.6). 
There was no statistical difference found between the ages of the two groups using the 
Student’s t test. 
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4.1.4 The relationship of the potential donors to the paediatric recipients 
 
When looking at the overall rates of referral for evaluation of the different relatives to the 
recipient, the recipients’ mothers made up 51.4% (57/111) of the potential referrals 
compared to the recipients’ fathers who made up 29.7% (33/111) and the other relatives 
who made up 18.9% (21/111) (see Table 4.2). There was no statistical difference found 
between the rates of referral of the different relatives for the two groups on chi-square 
testing (p=0.92).  
 
 
 
Table 4.2 Rates of referral of the different relatives as potential paediatric LD 
program donors 
 Black donors Other donors Total 
Mothers 23 (56%) 34 (48.6%) 57 (51.4%) 
Fathers 10 (24.4%) 23 (32.9%) 33 (29.7%) 
Other relative 8 (19.6%) 13 (18.7%) 21 (18.9%) 
Total 41 (100%) 70 (100%) 111 (100%) 
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4.1.5 The reasons for exclusion of paediatric LD program donors  
 
The prevalence of hypertension in the group of potential donors to the paediatric LD 
program was 17% (7/41) in the group of black donors and 1.4% (1/70) in the group of 
other donors. The prevalence of HIV in our black potential donors was 12% (5/41) and all 
the HIV positive donors were female. There were no HIV positive donors in the other 
donor group. The prevalence of obesity in the black donors was 7.3% (3/41) and in the 
other donor group 5.7% (4/70). The three black donors who were obese were female. 
Three of the four other donors who were obese were male. 
 
 
 
 As can be seen in Table 4.3, the most common reason for exclusion of a potential 
paediatric LD program donor was hypertension (8/51) followed in equal numbers by viral 
infections (7/51), obesity (7/51) and immunological incompatibility (7/51). Then came 
renal dysfunction (4/51), multiple renal arteries (3/51), “mistake” (patient received a DD 
graft before the LD kidney could be used) (2/51), “withdrew” (the donor changed their 
mind and declined to donate a kidney) (1/51) and a host of miscellaneous reasons (see 
Table 4.4). The viral infections in the black donor group were made up of HIV in five 
cases and hepatitis B in one case, whereas the other donor group had one case of hepatitis 
B.  
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When comparing the excluded black donors to the excluded other donors, statistical 
analysis showed that the two groups differed significantly from each other especially with 
regards to hypertension (p=0.015), viral infections (p=0.034) and immunological 
incompatibility (p=0.015) using the chi-square test. (See Table 4.3) 
 
 
Table 4.3 Reasons for exclusion of donors to black paediatric recipients (Black) VS 
donors to other paediatric recipients (Other)  
Reason Black – n (%) Other – n (%) Total – n (%) p 
Hypertension 7 (31.8)  1 (3.5) 8 (15.7) 0.015 
Viral infections 6 (27.3) 1 (3.5) 7 (13.7) 0.034 
Immunological 0  7 (24.1) 7 (13.7) 0.015 
Obesity 3 (13.6) 4 (13.8) 7 (13.7) NS 
Renal dysfunction 1 (4.6) 3 (10.3) 4 (7.8) NS 
Multiple vessels 2 (9.1) 1 (3.4) 3 (5.9) NS 
Mistake 0  2 (6.9) 2 (3.9) NS 
Withdrew 0 1 (3.5) 1 (2.0) NS 
Miscellaneous 3 (13.6) 9 (31.0) 12 (23.6) ND 
Total 22 (100) 29 (100) 51 (100)  
 
NS = not significant 
ND = not done 
Immunological = positive cross match indicating immunological incompatibility 
Mistake = the recipient received a DD graft before the LD kidney could be used 
Withdrew = the donor changed their mind and declined to donate a kidney 
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Table 4.4 Reasons for exclusion of paediatric LD program donors - The miscellaneous 
group 
Reason Black Donors (n) Other Donors (n) 
Recipient death 3 1 
Transfer to another unit 0 2 
Recipient stabilised 0 1 
Prior renal surgery 0 1 
Renal calculi 0 1 
Hypoplastic kidney 0 1 
Connective tissue disease 0 1 
Other source 0 1 
Total 3 9 
 
Transfer = transferring of the recipient to another unit before the transplant took place 
Recipient stabilised = the recipient’s renal function stabilised and he did not need a 
transplant by the end of the study period 
Other source = the recipient received a kidney from a different live donor 
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4.2 Comparison of the excluded paediatric LD program donors with a cohort of 
excluded adult LD program donors  
 
4.2.1 The age of the excluded paediatric LD program donors versus the age of the 
excluded adult LD program donors 
 
The average age of the excluded paediatric LD program donors was 37.1 years (SD +/- 
8.08) with the average age for the group of black donors being 36 years (SD +/- 7.4) and 
the average age of the group of other donors being 38 years (SD +/- 8.6). The average age 
of the excluded adult LD program donors was 36.5 years (SD +/- 9.14) with the average 
age for the black donors being 36.2 years (SD +/- 8.29) and the average age of the other 
donors being 36.7 years (SD +/- 9.91) (see Table 4.5). There was no statistical difference 
between the ages of the two groups using the Student’s t test.  
 
 
 
Table 4.5 The ages of the donors  
 Paediatric  donors Adult donors 
Age of all donors (yrs) 37.1 (SD +/- 8.08) 36.5 (SD +/- 9.14) 
Age of black donors (yrs) 36.0 (SD +/- 7.39) 36.2 (SD +/- 8.29) 
Age of other donors (yrs) 38.0 (SD +/- 8.6) 36.7 (SD +/- 9.91) 
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4.2.2 The rate of exclusion of the paediatric LD program donors versus the rate of 
exclusion of the adult LD program donors 
 
111 potential living donors (PLD) to the paediatric LD program were evaluated of which 
51 were excluded from donating and 60 were accepted for donation giving an overall 
exclusion rate of 45.9% (51/111). 381 potential living donors to the adult LD program 
were evaluated of which 226 were excluded from donating and 155 were accepted for 
donation giving an overall exclusion rate of 59.3% (226/381).  
 
 
 
When comparing the rate of exclusion of the paediatric LD program donors versus the rate 
of exclusion of the adult LD program donors, we see that the paediatric LD program 
donors were excluded less often than the adult LD program donors. This was statistically 
significant using the chi-square test (p=0.012). (See Table 4.6) 
 
 
  
 
 
 
 
 
 
 
38 
 
Table 4.6 Rates of exclusion of the paediatric LD program donors (Paed) VS the adult 
LD program donors (Adult)  
 
 
 
 
 
 
 
PLD = potential living donor                                            
ALD = accepted living donor 
XLD = excluded living donor 
 
 
 
 
 
 
 
 
 
 
 
 
 Paed Adult Total 
PLD 111 381 492 
ALD 60 155 215 
XLD 51 226 277 
% excluded 45.9% 59.3% 56.3% 
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4.2.3 The reasons for exclusion of the paediatric LD program donors versus the 
reasons for exclusion of the adult LD program donors 
 
As can be seen in Table 4.7, when comparing the paediatric LD program donors to the 
adult LD program donors, the two groups were the same for all the reasons of exclusion 
except for withdrawal of consent. The most common reasons for exclusion of a potential 
donor for both groups were hypertension, viral infections, obesity and immunological 
incompatibility. 
 
 
 
The adult group withdrew consent to donation far more often than the paediatric group. 
This was statistically significant on Chi-square testing (p=0.009) (see Table 4.7). When 
looking at the prevalence of withdrawal of consent in the two groups of potential donors, 
we see that 9% (35/381) of all potential donors to the adult LD program withdrew consent 
to donation compared to 0.9% (1/111) of all potential donors to the paediatric LD program.  
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Table 4.7 Reasons for exclusion of paediatric LD program donors (Paed) VS reasons 
for exclusion of adult LD program donors (Adult)  
Reason Paed – n (%) Adult – n (%) Total – n (%) p 
Hypertension 8 (15.7) 26 (11.4) 34 (12.3) NS 
Viral infections 7 (13.7) 25 (11.1) 32 (11.6) NS 
Immunological 7 (13.7) 37 (16.4) 44 (15.9) NS 
Obesity 7 (13.7) 28 (12.4) 35 (12.6) NS 
Renal dysfunction 4 (7.8) 19 (8.4) 23 (8.4) NS 
Multiple vessels 3 (5.9) 18 (8.0) 21 (7.6) NS 
Mistake 2 (3.9) 16 (7.1) 18 (6.4) NS 
Withdrew 1 (2.0) 35 (15.5) 36 (12.9) 0.009 
Miscellaneous 12 (23.6) 22 (9.7) 34 (12.3) ND 
Total 51 (100) 226 277  
 
NS = not significant 
ND = not done 
Immunological = positive cross match indicating immunological incompatibility 
Mistake = the recipient received a DD graft before the LD kidney could be used 
Withdrew = the donor changed their mind and declined to donate a kidney 
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5.0 DISCUSSION 
 
Recognizing the challenges facing a LD program, we set out to determine the rate of 
exclusion of potential donors to our paediatric LD transplant program and then to analyze a 
group of excluded potential live donors. We aimed to document their age, their relationship 
to the recipient and the reason for their exclusion as donors. We also set out to document 
and analyze any differences between the different population groups. We also postulated 
that the group of donors to paediatric recipients would differ from a previously studied 
group of donors to adult recipients (70), and that these differences might help us to refine 
our criteria for donor acceptance and exclusion.  
 
 
 
When examining the data with respect to the paediatric LD program donors, we found that 
even though there were different reasons for exclusion of potential donors from the 
different groups, there was no statistical difference found in the rate of exclusion between 
the black donor group and the other donor group (see Table 4.1). The overall exclusion rate 
for the potential donors in our study was 45.9% (51/111). This was similar to that reported 
by Riehle et al where, of 159 potential donor candidates, 68 were not used giving an 
overall exclusion rate of 42% (68/159) (14).  
 
 
 
We found that the recipients’ mothers were referred much more commonly for evaluation 
than the recipients’ fathers or other relatives. As can be seen in Table 4.2, mothers made up 
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51.4% (57/111) of the potential referrals compared to fathers who made up 29.7% (33/111) 
and the other relatives who made up 18.9% (21/111). There was no statistical difference in 
the referral rates of the different relatives between the two groups. We are not sure why 
there appears to be reduced referral rates for fathers compared to mothers. We could 
speculate that either the fathers were not around, or if they were, that they felt that as the 
main bread winners for the family they could not afford to take the risk presented by 
donation, albeit small. More research needs to be done on this matter.  
 
 
 
As can be seen in Table 4.3, the main reasons for exclusion of the paediatric LD program 
donors were firstly hypertension followed in equal numbers by viral infections, obesity and 
immunological incompatibility. When comparing the black paediatric donor group to the 
other paediatric donor group for the reasons for exclusion of a potential donor (see Table 
4.3), statistical analysis showed that the two groups differed significantly from each other 
especially with regards to hypertension (p=0.015) and viral infections (p=0.034) which 
were more common in the black donors, and immunological incompatibility (p=0.015) 
which was more common amongst the group of other donors. The viral infections in the 
black donor group were made up of HIV in five cases and hepatitis B in one case, whereas 
the other donor group had one case of hepatitis B and no cases of HIV. The rates of obesity 
were the same for the two groups. 
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As mentioned, our study found that the commonest reason for exclusion of a potential 
donor was hypertension with 15.7% (8/51) of all paediatric LD program donors excluded 
for this reason. In a similar study, Riehle et al reported that of 68 potential donors who 
were not used, 26.5% (18/68) were turned down because of hypertension (14).  
 
 
 
The fact that our results indicated that hypertension was significantly more common in 
black donors was not surprising. We found a prevalence of 17% (7/41) amongst our group 
of black potential donors which was much more than the 1.4% (1/70) prevalence for the 
other group of potential donors. In South Africa in general, studies of the prevalence of 
hypertension have shown differing rates due the effects of different population groups and 
regions. Rates have been reported to be as varied as 12,7% in the rural Eastern Cape (71), 
25% for rural Limpopo (72), and 55% in urban general practices where up to 50% of white 
patients and 59% of black patients were reported as being hypertensive (73).  In a random 
sample of 13 802 subjects aged 15 years or older, of whom 76% were black, 13% of mixed 
ancestry, 8% white, and 3% Indian/Asiatic, the age-adjusted incidence of hypertension for 
this predominantly black South African population was 21% (females and males had equal 
rates). For those more than 65 years of age, 50% to 60% were hypertensive (74). 
 
 
 
 It must be remembered that our two groups of donors had mean ages of 36 years (SD +/- 
7.4) and 38 years (SD +/- 8.6) for the black group and the other group respectively. The 
differences in the prevalence of hypertension between the two groups of excluded donors 
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probably reflects the fact that hypertension is more common in younger black people than 
in other race groups of the same age in South Africa. 
 
 
 
With nearly half of our population still rural, and much of the African urban population 
now rapidly adopting Western lifestyle habits, it is likely that the prevalence rates will 
increase with time (74) Keeping the above in mind, and knowing that our follow-up rates 
are less than ideal, we feel that it would not be in the donor’s best interests to lower our 
exclusion criteria for hypertension. 
 
 
 
Obesity was found to be a common reason to exclude a potential donor in both groups of 
donors to paediatric recipients, accounting for 13.7% (7/51) of all excluded donors. In the 
study by Riehle’s et al, of the 68 potential donors who were not used, only 1/68 (1.5%) 
was turned down because of obesity (14). The prevalence of obesity in our potential black 
donors was around 7.3% (3/41) and in the potential other donors it was 5.7% (4/70). 
Obesity is steadily becoming the greatest health problem in the developed world and has 
numerous serious medical sequelae (47) (48) (49). Obese donors may be at considerable 
surgical risk when undergoing nephrectomy and are also at risk for long term renal 
dysfunction post nephrectomy (50) (51).  
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The prevalence of obesity in South Africa varies between the different population groups 
and areas, with Puoane et al reporting rates of  6% and 18% for African and white males 
respectively and 31% and 22% for African and white females respectively (75). In that 
study there was a trend towards higher levels of obesity in the urban setting as compared 
with the non-urban setting, particularly for Africans (75). 
 
 
 
 The study also found that in South Africa, obesity in women seems to start at a young age, 
with 10% of women obese at the ages 15 to 24 years, and they therefore recommended that 
primary prevention of obesity must start at a young age, particularly for girls (75). In 
African women the highest rate of obesity was in urban women, and women with no 
education had lower BMIs than those with schooling, perhaps because they do more 
manual labour than their better educated counterparts (75).  
 
 
 
In our study, the three black donors excluded due to obesity were female, and in the other 
group three out of the four donors excluded because of obesity were male. The numbers we 
are dealing with are small, and it is difficult to know if this picture was due to the female 
black donors and male other donors having difficulty losing weight for the transplant, or 
whether this was just a reflection of the prevalence of obesity in the different communities. 
More research needs to be done on this matter. 
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We try to get our potential donors to lose weight if they are a good match with the recipient, 
but often this goal is not achieved. Also, weight gain post nephrectomy is of concern and 
potential donors need to be made aware of this possibility and given the means to prevent it. 
 
 
 
Viral infections, in particular HIV, were found to be an important cause of exclusion in the 
group of black donors to the paediatric LD program. In the study by Riehle et al, of the 68 
potential donors who were not used, 3% (2/68) were not used due to chronic hepatitis and 
there were no HIV positive potential donors in their cohort (14). 
 
 
 
HIV has been transmitted from both infected deceased donors as well as from infected 
living related donors with the development of the acquired immunodeficiency syndrome 
and ultimately death in the recipient (33) (34).  For this reason organ donor guidelines 
necessitate HIV infection in the donor to be a contraindication to organ donation (16) (54). 
 
 
 
The prevalence of HIV among our group of black potential donors was 12% (5/41) and all 
the HIV positive donors were female. This was in keeping with a comprehensive South 
African national community-based study which showed the estimated national prevalence 
of people living with HIV/AIDS to be at least 11.4%, although there was wide variation 
with regards to age, sex, race and location (76). Antenatal clinic prevalence was reported 
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as 24%. Both age, in particular being between 25 and 49 years, and being female, 
increased the likelihood of a person being HIV positive, with prevalence rates of 38.6%, 
29.7% and 17.5% reported for African women between the ages of 25-29, 30-34 and 35-39 
respectively (76). The report found that Africans had a higher prevalence of HIV (12.9%) 
than whites (6.2%) and that HIV prevalence was lower in rural areas and highest in urban 
informal areas (76).   
 
 
 
As mentioned above, in the study by Riehle et al no potential donors were found to have 
HIV (14), but in our situation it is a sad fact that, for the foreseeable future, we will be 
encountering more and more potential donors who will be HIV positive. The impact of 
diagnosing HIV infection in a potential donor is more than just the potential recipient not 
having access to a kidney. It will also affect long term care issues which may arise in the 
event of illness or death of an HIV infected caregiver, not to mention the social stigma still 
carried by this disease. As with all severe chronic illnesses, great understanding and care 
needs to be given to the potential donor and the family who will now have to deal with this 
new burden. Luckily, access to antiretroviral drugs is becoming a reality for the average 
South African, and so the outlook for a diagnosis of HIV is not as bleak as it once was.  
 
 
 
Immunological incompatibility occurred much more commonly as a reason for exclusion 
in the group of other donors compared to the group of black donors (p=0.015). In the study 
by Riehle et al, of the 68 potential donors who were not used, 10.3% (7/68) were not used 
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because of a positive cross match (14). In our study, 24.1% (7/29) of other donor group 
were excluded due to a positive cross match between the donor and the recipient as 
compared to none of the black donor group. This finding may have been due to increased 
referral rates of unrelated living donors in the other donor group but more research needs 
to done on this matter. If this is the case, this number can be expected to increase in the 
black donor group as our education of families on the need for LD transplantation 
improves.  
 
 
 
When comparing the group of excluded paediatric LD program donors with the group of 
excluded adult LD program donors, we had postulated that the donors to the paediatric 
program would be younger and therefore fitter than the donors to the adult program. We 
felt that this would have resulted in the paediatric LD program donors having lower rates 
of exclusion due to hypertension, obesity and viral infections such as HIV. This was not 
found to be the case. There was no difference found between the two groups in terms of 
their ages (see Table 4.5) and hence it was not surprising that, when looking at the medical 
reasons for exclusion of the adult donors compared to the paediatric donors, we found the 
two groups were essentially the same (see Table 4.7).  
 
 
 
However, we found a definite difference in the rate of exclusion of the paediatric donors 
compared to the adult donors. As can be seen in Table 4.6 the adult LD program donors 
were excluded significantly more frequently than the paediatric LD program donors 
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(p=0.012). When looking at the reason for this, we see in Table 4.7 that the only significant 
difference between the adult LD program group and the paediatric LD program group was 
in withdrawal of consent to donation. 15% (35/226) of excluded donors to the adult 
program were excluded due to withdrawal of consent compared with only 2% (1/51) of 
excluded donors to the paediatric program (p=0.009). In the study by Riehle et al, of the 68 
potential donors who were not used, 14.7% (10/68) were not used because of withdrawal 
of consent (14). 
 
 
 
In the group of donors to adult recipients, 9% (35/381) of all referred potential living 
donors were ultimately not used because they withdrew consent whereas in the group of 
donors to paediatric recipients less than 1% (1/111) of potential donors refused to donate a 
kidney. In the study by Riehle et al, 6.2% (10/159) of all potential donors were reported as 
refusing to donate after passing the initial screening process (14).  
 
 
 
It is of concern that the rate of withdrawal of consent in the group of donors to the adult 
LD program was so high.  Late withdrawal of consent implies the waste of a lot of time, 
resources and effort spent on working up the potential donor not to mention the delay in 
listing the recipient on the DD list and the disappointment to the recipient. The fact that 
potential donors to our paediatric LD program withdrew consent so infrequently reassures 
us that our selection and referral of potential donors for evaluation is appropriate.  
50 
 
We could speculate as to the reasons for the lower rates of withdrawal of the donors to the 
paediatric program. The most likely reason is that the parents and family of the recipient 
are more altruistically motivated to relieve the burden of ESRD placed on their child than a 
donor to an adult recipient would be. Perhaps it is due to feelings of guilt and pressure 
placed on the parents by their communities who may repeatedly enquire as to why the 
child has not yet been transplanted. It is also possible that there is an element of expected 
self-benefit on behalf of the parents. They may feel that it would be easier to care for their 
child once they have had a successful transplant compared to the effort involved in the 
rigours of ambulatory peritoneal dialysis or transporting the child to hospital for regular 
haemodialysis.  
 
 
 
A study on motives for becoming a living donor looked at donors to adult recipients and 
found that a wish to help was the strongest motive, but almost as highly ranked were self-
benefit due to the recipient’s anticipated improved health, and identification with the 
recipient (77). A gain in self-benefit by the donation was a strong motive particularly for 
spouses and parents (77). More research needs to be done on this matter. 
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6.0 CONCLUSION 
 
In conclusion, as noted in other studies, there are many reasons that a potential live kidney 
donor could be excluded (8) (14) (15) (16), and many of these reasons are lifestyle induced 
diseases such as hypertension and obesity. The opportunity to convert the potential donor 
to a healthier lifestyle (smoking cessation and weight reduction) should not be missed (12), 
but it is difficult for a paediatric nephrology unit to have an impact on these diseases which 
are perhaps more the domain of the public health specialists. We would add our voice to 
the strident calls for government involvement in the long term prevention of these 
conditions.  
 
 
 
It is important to address the question of excluding potential donors with hypertension, 
borderline renal dysfunction and even obesity. As the need for organ transplantation grows, 
we must ensure that the risk to the donor is not overlooked during the tally of financial 
benefit to society and the quality of life to the recipient (8). Increasing donation should not 
mean increasing risk to the donor; instead it should mean minimal long-term risk to the 
donor while maintaining the huge benefit to the recipient and society (8). Our donor 
follow-up is not optimal for a number of reasons and the principle of ‘first do no harm’ 
should be foremost in our decision making process.  
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Another relevant issue is that of the HIV positive child in ESRF who has an HIV positive 
live potential donor. Transplanting HIV positive recipients from HIV negative donors is 
accepted practice in many units worldwide (78) (79) although in South Africa at present,  
mainly due to financial constraints, there is great reluctance to offer transplantation and 
even chronic dialysis to HIV positive individuals. Does the era of highly active 
antiretroviral therapy (HAART) imply that, if both the HIV infected parent and child 
respond well to HAART, perhaps we could use the parent’s organ for the child? Would the 
attitude of the transplant community to HIV infection become similar to the cases of 
hepatitis and CMV where, as long as the recipient is immune or covered with antiviral 
agents (as in CMV), the transplant would take place (16) (58)? At present HIV-positive 
donors are not considered for HIV-infected recipients since there are concerns that this 
group of stable HIV-infected patients may be adversely affected by a different quasispecies 
of HIV (79). With the prevalence of HIV at epidemic proportions in South Africa, and 
more infections taking place each day, it is expected that this topic will be hotly debated in 
the future. 
 
 
 
Newer and better immunosuppressive therapy has resulted in better outcomes for DD and 
LD transplants with relaxation of the criteria for suitability of renal failure candidates for 
transplantation. However, the strict criteria outlined for the selection of living renal donors 
must remain relatively inflexible if we are to ensure the safety and long-term health of the 
donor (14). Ongoing donor monitoring is necessary to enable us to document long-term 
outcome in our donors. This will give us the tools to allow us to continually re-evaluate our 
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exclusion criteria based on solid evidence from our own population of donors with their 
own unique demographic picture.  
 
 
 
It was gratifying to see that although the rate of withdrawal of consent was high in the 
group of potential donors to the adult LD program at our hospital, it was almost non-
existent in the group of donors to paediatric recipients. This bodes well for our transplant 
program as we can feel confident that our donor selection criteria are good. 
 
 
 
Finally, it is important to note that in our unit the percentage of LD transplants performed 
have become similar for black and other recipients over the past few years (11). Our LD 
rates for black recipients (52%) are much higher than those reported for black recipients in 
a study from the USA which showed that family education could increase the LD 
transplant rate from 9.4% at 3 years post transplant evaluation to 16.6% (80). As 
mentioned before, it is reasonable to say that all our population groups have accepted the 
idea of LD transplantation as an ideal. In light of the decreasing availability and increasing 
demand for DD kidneys in South Africa this gives hope for the future of paediatric renal 
transplantation at Johannesburg Hospital. 
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APPENDIX A: The Data Capture Sheet 
Subject number Year Age Sex Race Relation Reason 
1 1989 37 female black Other HIV Positive 
2 1991 45 male white Female Mistake 
3 1992 45 male white Female Recipient not ready 
4 1993 43 female black Mother HIV Positive 
5 1993 44 male black Father Hypertension 
6 1993 36 female black Mother Obesity 
7 1993 32 male white Other Renal surgery 
8 1994 47 male black Father Hepatitis B 
9 1994 46 male white Other Obesity 
10 1994 34 female white Mother Multiple vessels 
11 1995 45 female black Mother Hypertension 
12 1995 26 female black Mother Hypertension 
13 1995 29 female black Mother Recipient died 
14 1996 36 male white Father Obesity 
15 1996 22 female white Mother Recipient died 
16 1997 41 female white Mother Immunological 
17 1997 31 female white Other Other source 
18 1997 46 female white Mother Renal dysfunction 
19 1998 41 male Asian Father Immunological 
20 1998 38 male white Other Immunological 
21 1998 49 male white Father Renal Calculi 
22 1999 31 male Asian Other Withdrew consent 
23 1999 39 male black Father Recipient died 
24 1999 52 female white Mother Renal dysfunction 
25 1999 37 female white Mother Renal dysfunction 
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Subject number Year Age Sex Race Relation Reason 
26 2000 32 male white Father Mistake 
27 2000 51 male white Other Immunological 
28 2000 28 male white Father Immunological 
29 2000 29 female white Mother Obesity 
30 2001 39 female black Mother HIV Positive 
31 2001 38 female black Mother Hypertension 
32 2001 30 male black Other Hypertension 
33 2001 35 female black Mother Multiple vessels 
34 2001 22 male black Other Multiple vessels 
35 2002 42 male Asian Father Transfer  
36 2002 37 female black Mother Obesity 
37 2002 52 female white Other Hypertension 
38 2002 37 female white Other Immunological 
39 2003 28 female black Mother HIV Positive 
40 2003 40 female black Mother Obesity 
41 2003 45 female black Mother Recipient died 
42 2003 23 female white Other Immunological 
43 2004 37 female black Mother HIV Positive 
44 2004 37 female black Mother Hypertension 
45 2004 20 male black Other Hypertension 
46 2004 39 female black Mother Renal dysfunction 
47 2004 42 female coloured Mother Connective tissue disease 
48 2004 33 female coloured Mother Hepatitis B 
49 2004 27 female white Mother Hypoplastic Kidney 
50 2004 32 male white Father Obesity 
51 2004 47 male white Father Transfer  
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